Arizona State Retirement System’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,614
Closed -$33.1K 2198
2023
Q1
$33.1K Buy
11,614
+906
+8% +$8.12K ﹤0.01% 2211
2022
Q4
$78K Buy
10,708
+428
+4% +$2.79K ﹤0.01% 2145
2022
Q3
$83K Buy
+10,280
New +$73.6K ﹤0.01% 2103

Other funds holding FULC

Arizona State Retirement System's FULC Position: Q2 2023 in Review

Arizona State Retirement System sold out of Fulcrum Therapeutics (FULC) in Q2 2023, closing a stake of 11,614 shares — an estimated $33.1K sold.

Arizona State Retirement System first reported a position in FULC in Q3 2022 and held it in 3 quarters. The position peaked at $83K in Q3 2022. 88 funds tracked by Wall St. Rank hold FULC as of Q2 2023.

  • Arizona State Retirement System reported no remaining Fulcrum Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 11,614 Fulcrum Therapeutics shares in Q2 2023, an estimated $33.1K.
  • Arizona State Retirement System first reported a position in Fulcrum Therapeutics in Q3 2022 and held it in 3 quarters.
  • Arizona State Retirement System's Fulcrum Therapeutics position peaked at $83K in Q3 2022.
  • 88 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2023.

Based on Arizona State Retirement System's 13F filing for Q2 2023, filed 1 Aug 2023.